Clinical trial
Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children
NCT07398261 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children
- Lead sponsor
- Menoufia University
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- November 28, 2023
- Completion date
- November 1, 2026
- Enrollment
- 151 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
treatment of non-monosymptomatic nocturnal enuresis